These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 26227059

  • 1. MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer.
    Chen QG, Zhou W, Han T, Du SQ, Li ZH, Zhang Z, Shan GY, Kong CZ.
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):213-24. PubMed ID: 26227059
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N, Zhang QY, Zou JL, Li ZW, Tian TT, Dong B, Liu XJ, Ge S, Zhu Y, Gao J, Shen L.
    Oncotarget; 2016 Jan 26; 7(4):4817-28. PubMed ID: 26716895
    [Abstract] [Full Text] [Related]

  • 7. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
    Liu C, Guan H, Wang Y, Chen M, Xu B, Zhang L, Lu K, Tao T, Zhang X, Huang Y.
    PLoS One; 2015 Jan 26; 10(12):e0144073. PubMed ID: 26650737
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
    Xue H, Guo X, Han X, Yan S, Zhang J, Xu S, Li T, Guo X, Zhang P, Gao X, Liu Q, Li G.
    Oncotarget; 2016 Jan 26; 7(4):4785-805. PubMed ID: 26715733
    [Abstract] [Full Text] [Related]

  • 10. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
    Lian J, Jing Y, Dong Q, Huan L, Chen D, Bao C, Wang Q, Zhao F, Li J, Yao M, Qin L, Liang L, He X.
    Oncotarget; 2016 Jan 19; 7(3):2672-83. PubMed ID: 26684241
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.
    Wang L, Jiang CF, Li DM, Ge X, Shi ZM, Li CY, Liu X, Yin Y, Zhen L, Liu LZ, Jiang BH.
    Oncotarget; 2016 Jan 19; 7(3):2660-71. PubMed ID: 26673620
    [Abstract] [Full Text] [Related]

  • 12. MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo.
    Chen QG, Zhou W, Han T, Du SQ, Li ZH, Zhang Z, Shan GY, Kong CZ.
    Tumour Biol; 2016 Feb 19; 37(2):2095-103. PubMed ID: 26346167
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.
    Cheng Y, Yang X, Deng X, Zhang X, Li P, Tao J, Lu Q.
    Tumour Biol; 2015 Sep 19; 36(10):8015-23. PubMed ID: 25967457
    [Abstract] [Full Text] [Related]

  • 16. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
    Tao T, Chen M, Jiang R, Guan H, Huang Y, Su H, Hu Q, Han X, Xiao J.
    Oncol Rep; 2017 Mar 19; 37(3):1430-1436. PubMed ID: 28184935
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
    Zheng M, Sun X, Li Y, Zuo W.
    Tumour Biol; 2016 Jun 19; 37(6):8189-96. PubMed ID: 26715279
    [Abstract] [Full Text] [Related]

  • 18. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
    Sun C, Huang C, Li S, Yang C, Xi Y, Wang L, Zhang F, Fu Y, Li D.
    Oncotarget; 2016 Feb 16; 7(7):8341-59. PubMed ID: 26840018
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. miR-134 suppresses the migration and invasion of non‑small cell lung cancer by targeting ITGB1.
    Qin Q, Wei F, Zhang J, Li B.
    Oncol Rep; 2017 Feb 16; 37(2):823-830. PubMed ID: 28075475
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.